Mon, May 03 | NA

New Cancer Immunotherapy Targets Genetic Alteration in All Cancers

Researchers have developed a prototype for a new kind of cancer immunotherapy. The therapy uses engineered T-cells to target a genetic alteration common among all cancers.
Registration is Closed
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers

Time & Location

May 03, 7:00 PM
NA
Registration is Closed

Share This Event